Supplemental material
Bioengineered
Volume 13, 2022 - Issue 3
Open access
1,595
Views
2
CrossRef citations to date
0
Altmetric
Research Paper
Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway
Youhan MiaoDepartment of Infectious Diseases, The Third People’s Hospital of Nantong, Nantong, Jiangsu, ChinaView further author information
, Meihua WangDepartment of Infectious Diseases, The Third People’s Hospital of Nantong, Nantong, Jiangsu, ChinaView further author information
, Xiaojuan CaiDepartment of Infectious Diseases, The Third People’s Hospital of Nantong, Nantong, Jiangsu, ChinaView further author information
, Qiqi ZhuDepartment of Infectious Diseases, The Third People’s Hospital of Nantong, Nantong, Jiangsu, ChinaView further author information
& Liping MaoDepartment of Infectious Diseases, The Third People’s Hospital of Nantong, Nantong, Jiangsu, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 7316-7327
|
Received 28 Dec 2021, Accepted 25 Feb 2022, Published online: 10 Mar 2022
Related Research Data
Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGF��1)/SMAD signaling pathway
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.